Pentose Phosphate Pathway – Function and Clinical Role
The pentose phosphate pathway is a key metabolic route in human cells that processes glucose to produce NADPH and ribose-5-phosphate, supporting antioxidant defense and DNA synthesis.
Things worth knowing about "Pentose Phosphate Pathway"
The pentose phosphate pathway is a key metabolic route in human cells that processes glucose to produce NADPH and ribose-5-phosphate, supporting antioxidant defense and DNA synthesis.
What is the Pentose Phosphate Pathway?
The pentose phosphate pathway (PPP), also known as the phosphogluconate pathway or hexose monophosphate shunt, is a fundamental metabolic pathway that runs parallel to glycolysis in the cytoplasm of cells. It processes glucose-6-phosphate and serves two primary biological functions: the generation of NADPH (a critical cellular reducing agent) and the production of ribose-5-phosphate, an essential building block for nucleotide and nucleic acid synthesis.
This pathway is present in virtually all living organisms and is indispensable for protecting cells against oxidative stress, supporting biosynthesis, and maintaining cellular homeostasis.
Phases of the Pentose Phosphate Pathway
Oxidative Phase
The first, irreversible phase begins with the oxidation of glucose-6-phosphate by the enzyme glucose-6-phosphate dehydrogenase (G6PD). The main products are:
- NADPH – a reducing equivalent required for fatty acid synthesis, cholesterol metabolism, and the neutralization of reactive oxygen species (ROS)
- Ribose-5-phosphate – a pentose sugar serving as a precursor for nucleotide synthesis (building blocks of DNA and RNA)
- CO₂ – released as a byproduct of decarboxylation
Non-Oxidative Phase
The second, reversible phase involves the enzymatic interconversion of sugar phosphates through transketolase and transaldolase. This phase allows intermediates to re-enter glycolysis and provides metabolic flexibility, enabling the cell to balance energy demands with biosynthetic needs.
Biological Significance
Protection Against Oxidative Stress
NADPH is essential for regenerating glutathione, one of the most important cellular antioxidants. Red blood cells (erythrocytes) rely entirely on the pentose phosphate pathway for NADPH production, as they lack mitochondria. A deficiency in G6PD impairs this protection and renders erythrocytes highly susceptible to oxidative damage, potentially triggering hemolytic anemia.
Nucleotide Biosynthesis
Ribose-5-phosphate is a crucial precursor for synthesizing ATP, NADH, coenzyme A, and the genetic molecules DNA and RNA. Rapidly dividing tissues such as bone marrow, intestinal epithelium, and cancer cells exhibit particularly high pentose phosphate pathway activity to meet their nucleotide demands.
Fatty Acid and Steroid Biosynthesis
NADPH is also required for the biosynthesis of fatty acids and steroids, including cholesterol and steroid hormones. Tissues with high lipogenic activity, such as the liver and mammary glands, therefore show elevated activity of this pathway.
Clinical Relevance
G6PD Deficiency
Glucose-6-phosphate dehydrogenase deficiency is the most common enzyme deficiency worldwide, affecting an estimated 400 million people. It is inherited in an X-linked recessive pattern, predominantly affecting males. Affected individuals may experience acute hemolytic anemia when exposed to certain drugs (e.g., primaquine, high-dose aspirin), fava beans (a condition known as favism), or during infections due to increased oxidative stress on erythrocytes.
Role in Oncology
Cancer cells frequently upregulate the pentose phosphate pathway to satisfy the high demand for nucleotide precursors needed for rapid proliferation and to generate NADPH to counteract oxidative stress. This makes key enzymes of the pathway attractive targets for cancer therapy, with several inhibitors currently under investigation.
Regulation of the Pentose Phosphate Pathway
The rate-limiting enzyme glucose-6-phosphate dehydrogenase is the primary regulatory control point of this pathway. High intracellular NADPH levels inhibit the enzyme via negative feedback, while increased demand for NADPH or ribose-5-phosphate stimulates pathway flux. Hormonal signals such as insulin can also upregulate enzyme expression, particularly in lipogenic tissues.
References
- Berg JM, Tymoczko JL, Stryer L. Biochemistry. 8th Edition. W.H. Freeman and Company, 2015.
- Nelson DL, Cox MM. Lehninger Principles of Biochemistry. 7th Edition. W.H. Freeman and Company, 2017.
- Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012;64(5):362-369. PubMed PMID: 22431005.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pentose Phosphate Pathway-en